FibroBiologics, Inc. Common Stock (FBLG) — Financial Flexibility Index
FibroBiologics, Inc. Common Stock (FBLG) has a Financial Flexibility Index of -0.46x as of September 2025. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $6.00K) represents 0% of total liabilities ($8.62 Million). Check FibroBiologics, Inc. Common Stock tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
FibroBiologics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for FibroBiologics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see FibroBiologics, Inc. Common Stock operating cash flow efficiency.
Annual Financial Flexibility Index for FibroBiologics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for FibroBiologics, Inc. Common Stock. Explore FibroBiologics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.85x | $-11.72 Million | $-11.90 Million | $13.71 Million | ▼ -52.9% |
| 2024 | -0.56x | $-5.91 Million | $-6.40 Million | $10.57 Million | ▼ -21.2% |
| 2023 | -0.46x | $-4.07 Million | $-4.07 Million | $8.82 Million | ▲ +42.5% |
| 2022 | -0.80x | $-1.41 Million | $-1.41 Million | $1.76 Million | — |